Verhoef LM, den Broeder N, Thurlings, et al. Ultra-low doses of rituximab or retreatment of rheumatoid arthritis: a randomised controlled non-inferiority trial. EULAR 2019; Madrid: Abstract LB0010.
Beeldvorming ondersteunt certolizumab bij SpA
mei 2018 | Spondyloartritis